Early research (Phase 1)WithdrawnNCT05262842What this trial is testingJS001+IMP4297 in Patients With Advanced CancerWho this might be right forAdvanced Cancer Shanghai Junshi Bioscience Co., Ltd.
Early research (Phase 1)Study completedNCT03250832What this trial is testingStudy of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid TumorsWho this might be right forNeoplasms Tesaro, Inc. 111
Testing effectiveness (Phase 2)Study completedNCT02423863What this trial is testingIn Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®Who this might be right forMelanomaHead and Neck CancerSarcoma+1 more Oncovir, Inc. 26
Early research (Phase 1)Study completedNCT03667716What this trial is testingCOM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.Who this might be right forAdvanced CancerOvarian CancerBreast Cancer+7 more Compugen Ltd 121
Not applicableStudy completedNCT03197636What this trial is testingCo-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma PatientsWho this might be right forMalignant Melanoma Aarhus University Hospital 40
Testing effectiveness (Phase 2)UnknownNCT06509971What this trial is testingQL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian CancerWho this might be right forPlatinum-resistant Recurrent Ovarian Cancer West China Second University Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04080804What this trial is testingStudy of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck CancerWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC) Dan Zandberg 80
Testing effectiveness (Phase 2)Study completedNCT03463681What this trial is testingCaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaWho this might be right forMetastatic Renal Cell Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Early research (Phase 1)Study completedNCT02529072What this trial is testingNivolumab With DC Vaccines for Recurrent Brain TumorsWho this might be right forMalignant GliomaAstrocytomaGlioblastoma Gary Archer Ph.D. 6
Testing effectiveness (Phase 2)Looking for participantsNCT06367075What this trial is testingA Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue SarcomaWho this might be right forAdvanced Soft-tissue Sarcoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT02422381What this trial is testingMK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Providence Health & Services 16
Not applicableStudy completedNCT03222440What this trial is testingCombination of Radiotherapy and SHR-1210 to Treat Patients With ESCCWho this might be right forEsophageal Cancer Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04815408What this trial is testingPD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian CancerWho this might be right forOvarian CancerNeoadjuvant ChemotherapyAnti-PD-1+1 more Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Early research (Phase 1)Study completedNCT04418401What this trial is testingStudy on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC PatientsWho this might be right forHepatocellular Carcinoma Zhejiang University 30
Testing effectiveness (Phase 2)Ended earlyNCT03645876What this trial is testingSHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)UnknownNCT04098796What this trial is testingPD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric or Gastroesophageal Junction AdenocarcinomaAFP China Medical University, China 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560What this trial is testingA Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerWho this might be right forPancreatic Cancer Lei Zheng 25
Testing effectiveness (Phase 2)UnknownNCT04446091What this trial is testingA Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)Who this might be right forColorectal Cancer Zhejiang Cancer Hospital 40
Not applicableNot Yet RecruitingNCT07139587What this trial is testingThe Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Qingxia Li 30
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438